Home / Press / CMS Hasche Sigle advises LSP Life Sciences Partners...

CMS Hasche Sigle advises LSP Life Sciences Partners on Series A round of financing for Curetis AG

07/12/2009

Munich – A consortium of leading life-science investors is putting EUR 18.5 million into Curetis AG, a German medical diagnostics company. The international consortium consists of four investors: LSP Life Sciences Partners, BioMedPartners, the KfW’s ERP start-up fund, and aeris CAPITAL, which also invested in Curetis back in 2008.

A team from CMS Hasche Sigle led by lead partner Stefan-Ulrich Müller advised LSP Life Sciences Partners on all aspects of the transaction. CMS Hasche Sigle has advised LSP Life Sciences Partners on investments and divestments in Germany on several occasions, including its investment and divestment at U3 Pharma AG and its investment in Affectis Pharmaceuticals AG.

Curetis AG plans to use this funding to drive development of its innovative diagnostic products through to the market stage. Founded in 2007, the company specialises in developing fast and reliable molecular tools for diagnosing serious bacterial infections (e.g. pneumonia) and more efficient identification of treatment options.

With offices in Amsterdam, Munich and Boston, LSP Life Sciences Partners is a leading European investor that provides financing to private and public life-science companies. LSP has been a founding investor in a large number of innovative companies, many of which have grown to become leaders of the global life-science industry, such as Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management, LSP is one of Europe's largest and most experienced life-science investors.

Advisers CMS Hasche Sigle on behalf of LSP Life Sciences Partners:

  • Stefan-Ulrich Müller, Corporate (Lead Partner)
  • Sebastian Wilhelm, Corporate
  • Dr Rupert Doehner, Corporate
  • Stefan Lüft, IP
  • Dr Martin Triemel, Employment Law
  • Stefan Lehr, Competition
  • Cornelia Hörnig, Competition

Contact:

Stefan-Ulrich Müller
+49 89 23807 197
Stefan-Ulrich.Mueller@cms-hs.com

Press releases
091207_LSP_Curetis_en
Download
PDF 176 kB

Related people

Portrait ofStefan-Ulrich Müller
Stefan-Ulrich Müller, M. Jur. (Oxford)
Partner
Munich